“…Some mechanisms for modulating cancer signaling and metabolic pathways with EGCG have been proposed based on numerous studies in cells, such as TNF, PI3K/Akt/mTOR, p53, p38 MAPK, and NF‐κB pathways (Chan, Lee, Wang, Yeh, & Liang, ; Elguindy, Yacout, El Azab, & Maghraby, ; Li et al, ; Rady et al, ; Wang, Wang, Wan, Yang, & Zhang, ). Our previous studies also found that EGCG, as well as EC, ECG, and EGC, may bind to some cancer‐related proteins in TPK‐RAS‐MAPK and NF‐κB signaling pathways when used molecular docking of these bioactive substances (Zheng, Chen, & Lu, ).…”